PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
23.59%
Revenue growth exceeding 1.5x CRWD's 5.94%. David Dodd would verify if faster growth reflects superior business model.
58.38%
Cost growth above 1.5x CRWD's 7.31%. Michael Burry would check for structural cost disadvantages.
15.95%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
-6.19%
Both companies show margin pressure. Martin Whitman would check industry conditions.
84.42%
R&D growth above 1.5x CRWD's 3.75%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.58%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
71.27%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-8.54%
Both companies reducing D&A. Martin Whitman would check industry patterns.
-57.57%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-72.17%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-53.14%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-62.09%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
11.16%
Other expenses growth 50-75% of CRWD's 18.80%. Bruce Berkowitz would examine cost efficiency.
-40.73%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-52.05%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-40.71%
Both companies reducing tax expense. Martin Whitman would check patterns.
-40.74%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-52.05%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-41.67%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-41.67%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.01%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
0.13%
Diluted share reduction exceeding 1.5x CRWD's 0.59%. David Dodd would verify capital allocation.